PBMC immune therapy added during fertility treatment
Part of Women’s health & pregnancy clinical trials.
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently receiving assisted reproduction (fertility) treatment
- You have primary infertility (you have not been able to get pregnant before)
- Your menstrual cycles are regular
- You can and will sign informed consent
- You likely do NOT have known uterine lining problems or infections, and you do not have active inflammation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether testing the lining of the womb before a single embryo transfer can help doctors choose the best treatment for you. It compares outcomes for people who had this testing with those who did not, to see if it improves the chance of a successful pregnancy.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This trial studies whether placing your own immune cells (PBMCs) that have been adjusted with a medicine called IFN-<i>t</i> before embryo transfer can improve IVF success. It may help support the uterine environment around the time of implantation.
This study gives a small amount of your own immune cells into the uterus to change the immune environment in the uterine lining. It aims to improve how the uterine lining supports implantation, especially for people trying to conceive with embryo transfer of normal (euploid) embryos.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.